ARIS Earnings

ARIS reported its earnings on 2026-05-06, showcasing a revenue of 372.48M against an estimate of , resulting in a 0% surprise. The EPS was 0.57, surpassing the expected 0.62 by -8.06%. The stock experienced a 0.42% price change on the earnings day and a 7.82% change over the next five days, reflecting market reactions to the results.

Following ARIS's earnings announcement on 2026-05-06, the stock price moved by 0.42% on the day of the release. Over the subsequent five days, it saw a 7.82% change. Historically, ARIS's stock price tends to shift by an average of 1.56% in the 10 days leading up to earnings and 9.18% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate ARIS's annual revenue to reach 121.63M, while the EPS is projected at 0.42. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ARIS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ARIS's stock price typically moves by 1.56% in the 10 days before its earnings and 9.18% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.42 and revenue of 121.63M.

The earnings call highlights strong financial performance with increased revenue, EBITDA, and cash flow. The strategic plan outlines significant production growth and expansion projects, aiming for 1 million ounces annually. Despite some regulatory and operational risks, the positive financial metrics, reduced net debt, and robust production guidance suggest a favorable stock outlook. The Q&A section confirms management's clarity and focus on long-term growth, reinforcing a positive sentiment. Given the absence of market cap data, a conservative positive prediction is appropriate, expecting a 2% to 8% stock price increase.